Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model
Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model
Recruiting · NCT06880419 · Registry updated 2025-08-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model | Acute Graft-versus-Host Disease | Recruiting | Phase 2 | 2025-08-08 | NCT06880419 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Hematology & Blood Diseases Hospital | Tianjin | China | 24 |